Antidepressants in the elderly: a review

Bibliography

• TURNER N, SCARPACE PJ, LOWENTHAL DT: Geriatricpharmacology: basic and clinical considerations. Annu. Rev. Pharmacol Toxicol(1992) 32:271–302.
   PubMed Web of Science ®Google Scholar
• SCHARF S, CHRISTOPHIDIS N: Relevanceofpharma-cokineticsandpharmacodynamics.Med. J. Aust.(1993) 158:395–402.
   Google Scholar
• SWIFT CG: Pharmacodynamics:changesinhome-stylemechanisms, receptor and target organ sensitivity in theelderly.Br. Med. Bull.(1990) 46:36–52.
   PubMed Web of Science ®Google Scholar
• WALLEY T, SCOTT AK: Prescribingintheelderly.Post-grad. Med.(1995) 71:466–471.
   Web of Science ®Google Scholar
• MONTAMAT SC, CUSACK BJ, VESTAL RE: Managementofdrugtherapyintheelderly.New Engl. J. Med.(1989) 321:303–309.
   PubMed Web of Science ®Google Scholar
• LEBOWITZ BD, PEARSON JL, SCHNEIDER LS et al.:Diag-nosis and treatment of depression in late life consen-susstatementupdate.JAMA(1997) 278:1186-1190.
   Google Scholar
• FORSELL Y, WINBLAD B: Majordepressioninapopula-tion of demented and nondemented older people: prevalenceandcorrelates.JAGS(1998) 46:27–30.
   Google Scholar
• GIRLING DM, BARKLEY C, PAYKEL ES et al.:Thepreva-lenceofdepressioninacohortoftheveryelderly.J. Af-fect. Disord.(1995) 34:319-329.
   Google Scholar
• FLINT AJ, RIFAT SL: Theeffectoftreatmentonthetwoyearcourseoflatelifedepression.Br. J. Psychiat.(1997) 170:268–272.
   Google Scholar
• MEATS P, TIMOL M, JOLLEY D: Prognosisofdepressionintheelderly.Br. J. Psychiat.(1991) 159:659–663.
   PubMed Web of Science ®Google Scholar
• O'BRIEN JT, AMES D, SCHWIETZER I: Whitematterchanges in depression and Alzheimer's disease: a re-viewofmagneticresonanceimagingstudies.Int. J. Geriatr. Psychiat.(1996) 11:681–694.
   Google Scholar
• GHOSE K: Toleranceandsideeffectsofparoxetineinelderlydepressedpatients.Arch. Gerontol. Geriatr.(1997) 24:35–45.
   Google Scholar
• GERETSEGGER C, BOHMER F, LUDWIG M: Paroxetineinthe elderly depressed patient: randomized compari-son with fluoxetine of efficacy, cognitive and behav-iouraleffects.Int. Clin. Psychopharmacol.(1994) 9:25–29.
   Google Scholar
• HUTCHINSON DR, TONG S, MOON CA et al.:Paroxetinein the treatment of elderly depressed patients in gen-eral practice: a double-blind comparison with amitrip-tyline.Int. Clin. Psychopharmacol.(1992) 6\(Suppl. 4):43–51.
   Google Scholar
• SCHONE W, LUDWIG M: Adouble-blindstudyofpar-oxetine compared with fluoxetine in geriatric patients withmajordepression.J. Clin. Psychopharmacol(1993) 13\(Suppl. 2):34S–39S.
   Google Scholar
• GUILLIBERT E, PELICIER Y, ARCHAMBAULT JC et al.:Adouble-blind,multicentrestudyofparoxetineversusclomipramineindepressedelderlypatients.Acta Psy-chiatr. Scand.(1989) 80\(Suppl. 350):132–134.
   Google Scholar
• DUNNER LD, COHN JB, WALSHE T et al.:Twocombined,multicenter double-blind studies of paroxetine and doxepiningeriatricpatientswithmajordepression.J. PsychiaL(1992) 53:57–60.
   Google Scholar
• DUNBAR GC: Paroxetineintheelderly:acomparativemeta-analysis against standard antidepressant phar-macotherapy.Pharmacology(1995) 51:137-144.
   Google Scholar
• FEIGHNER JP, BOYER WF, MEREDITH CH et al.:Anover-viewoffluoxetineingeriatricdepression.Br. J. Psy-chiaL(1988) 153:105–108.
   Google Scholar
• HUYSE FJ, ZWAAN WA, KUPAK R: Theapplicabilityofantidepressants in the depressed medically ill: an openclinicaltrialwithfluoxetine.J. Psychosom. Res.(1994) 38:695–703.
   Google Scholar
• FEIGHNER JP, COHN JB: Double-blindcomparativetri-als of fluoxetine and doxepin in geriatric patients with majordepressivedisorder.J. Clin. PsychiaL(1985) 46:20–25.
   Google Scholar
• TOLLEFSON GD, HOLMAN SL: AnalysisoftheHamiltonDepression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric ma-jordepression.Int. Gun. Psychopharmacol.(1993) 8:253–259.
   Google Scholar
• EVANS ME, LYE M: Depressionintheelderlyphysicallyill: an open study of treatment with the 5-HT reuptake inhibitorfluoxetine.J. Clin. Exp. Gerontol.(1992) 14:297–307.
   Google Scholar
• MESTERS P, COSYNS P, DEJAIFFE G et al.:Assessmentofquality of life in the treatment of major depressive dis-order with fluoxetine, 20 mg, in ambulatory patients agedover60years.Int. J. Psychopharmacol.(1993) 8:337–340.
   Google Scholar
• KERR JS, FAIRWEATHER DB, HINDMARCH I: Effectsoffluoxetine on psychomotor performance cognitive functionandsleepindepressedpatients.Int. J. Psycho-pharmacol.8:341–343.
   Google Scholar
• EVANS ME, HAMMOND M, WILSON K et al.:Placebo-controlled treatment trial of depression in elderly physicallyillpatients.Int. J. Geriatr. PsychiaL(1997) 12:817–824.
   Google Scholar
• ROOSE SP, GLASSMAN AH, ATTIA E et al:Cardiovasculareffects of fluoxetine in depressed patients with heart disease.Am. J. PsychiaL(1998) 155:660–665.
   Google Scholar
• BRYMER C, WINOGRAD CH: Fluoxetineinelderlypa-tients:istherecauseforconcern?JAGS(1992) 40:902–905.
   Google Scholar
• SMALL GW, BIRKETT M, MEYERS BS et al:Impactofphysical illness on quality of life and antidepressant responseingeriatricmajordepression.J. Am. Geriatr. Soc.(1996) 44:1220–1225.
   Google Scholar
• NYTH AL, GOTTRIES CG, SMEDEGAARD-ANDERSEN L etal:Acontrolledmulticenterclinicalstudyofcitalo-pram and placebo in elderly depressed patients with andwithoutconcomitantdementia.Acta PsychiaL Scand.(1992) 86:138–145.
   Google Scholar
• OVERO FK, TOFT B, CHRISTOPHERSEN L et al:Kineticsofcitalopraminelderlypatients.Psychopharmacology(1985) 86:253–257.
   Google Scholar
• MENTING JEA, HONIG A, VERHEY FRJ et al.:Selective se-rotonin reuptake inhibitors in the treatment of elderly depressedpatients.Int. Clin. Psychopharmacol.(1996) 11:165–175.
   Google Scholar
• GEORGOTAS A, MCCUE RE, FRIEDMAN E et al.:Responseof depressive symptoms to nortriptyline, phenelzine andplacebo.Br. J. PsychiaL(1987) 151:102-106.
   Google Scholar
• FLINT AF, RIFAT SL: Anxiousdepressioninelderlypa-tients.Am. J. Geriatr. PsychiaL(1997) 5:107–115.
   Google Scholar
• GEORGOTAS A, MCCUE RE, COOPER TB: Placebo-controlled comparison of nortriptyline and phenelz-Me in maintenance therapy of elderly depressed pa-tients.Arch. Gen. PsychiaL(1989) 46:783–786.
   Google Scholar
• ROTH M, MOUNTJOY CQ, AMRIEN R et al.:Moclobemidein elderly patients with cognitive decline and depres-sion.Br. J. PsychiaL(1996) 168:149-157.
   Google Scholar
• DE VANNA M, KUMMER J, AGNOLI A et al.:Moclobemidecompared with second generation antidepressants in elderlypeople.Acta Psychiatr. Scand.(1990) (Suppl. 360):64–66.
   Google Scholar
• NAIR NPV, AMIN M, HOLM P et al.:Moclobemide andnor-triptylineinelderlydepressedpatients.J. Affect. Dis-ord.(1995) 33:1–9.
   Google Scholar
• HOYBERG 0J, MARAGAKISS B, MULLIN J et al.:Adouble-blind multicentre comparison of mirtazapine and amitriptylineinelderlydepressedpatients.Acta Psy-chiatr. Scand.(1996) 93:184-190.
   Google Scholar
• WAITE J, GRUNDY E, ARIE T: Acontrolledtrialofantide-pressantmedicationinelderlyin-patients.Int. Clin. Psychopharmacol(1986) 1:113-126.
   Google Scholar
• ALTAMURA AC, MAURI MC, COLACURIO F et al.:Trazo-done in late life depressive states: a double-blind multi-centerstudyversusamitriptylineandmianserin.Psychopharmacology(1988) 95:S34–536.
   Google Scholar
• SINCLAIR JM, WALSH MR, VALLE-JONES JC et al.:Treat-ment of anxiety/depressive conditions in the elderly: a double-blind comparative study of motival and amitriptyline.Age Ageing(1975) 4:226–231.
   Google Scholar
• GERETSEGGER C, STUPPAECK CH, MAIR M et al.:Multi-center double-blind study of paroxetine and amitrip-tyline in elderly depressed in-patients. Psychopharmacology(1995) 119:277–281.
   PubMed Web of Science ®Google Scholar
• FLINT AJ, RIFAT SL: Theeffectofsequentialantidepres-santtreatmentongeriatricdepression.J. Affect. Disord.(1996) 36:95–105.
   Google Scholar
• REYNOLDS CF, FRANK E, PEREL JM et al.:Treatmentofconsecutive episodes of major depression in the eld-erly.Am. J. PsychiaL(1994) 151:1740–1743.
   Google Scholar
• FAIRBURN AF, GEORGE K, DORMAN T: Lofepramineversusdothiepininthetreatmentofdepressionineld-erlypatients.Br. J Clin. Pract.(1989) 43:55-60. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs(1999) 8(1)
   Google Scholar
• TAN RSH, BARLOW RJ, ABEL C et al.:Theeffectoflow doselofepramine in depressed elderly patients in gen-eralmedicalwards.Br. J. Clin. Pharmacol.(1994) 37:321–324.
   Google Scholar
• SCHIFANO F, GARBIN A, RENESTO V et al.:Adouble-blind comparison of mianserin and maprotiline in de-pressedmedicallyillelderlypeople.Acta Psychiat. Scand.(1989) 81:298–294.
   Google Scholar
• PHANJO0 AL, WONNACOTT S, HODGSON A: Adouble-blind comparative multicenter study of fluvoxamine and mianserin in the treatment of major depressive episodesinelderlypeople.Acta Psychiat. Scand.(1991) 83:476–479.
   Google Scholar
• EKLUND K, DUNBAR GC, PINDER RM et al.:Mianserinand imipramine in the treatment of elderly depressed patients.Acta Psychiat. Scand.(1985) 72\(Suppl. 32054–59.
   Google Scholar
• ALTAMURA AC, MAURI MC, COLACURCIO F et al.:Trazo-done in late life depressive states: a double-blind multi-centerstudyversusamitriptylineandmianserin.Psychopharmacology(1988) 95:S34–S36.
   Google Scholar
• ATHER SA, ANKIER SI, MIDDLETON RSW: Adouble-blindevaluation of trazodone in the treatment of depression intheelderly.Br. J. Clin. Pract.(1985) 39:192-199.
   Google Scholar
• BAYER AF, PATHY MS, CAMERON A et al.:Acomparativestudy of conventional and controlled release formula-tionsoftrazodoneinelderlydepressedpatients.Clin. Neuropharmacol.(1989) 12\(Suppl. 1):S50–S55.
   Google Scholar
• BAYER AJ, PATHY MSJ, ANKIER SI: Pharmacokineticandpharmacodynamic characteristics of trazodone in the elderly.Br. J. Clin. Pharmacol(1983) 16:371–376.
   PubMed Web of Science ®Google Scholar
• MAHAPATRA SN, HACKETT D: Arandomised,double-blind parallel group comparison of venlafaxine and dothiepin in geriatric patients with major depression. Int. J. Clin. PracL(1997) 51:209–213.
   PubMed Web of Science ®Google Scholar
• RAHMAN MK, AKTAR MJ, SHARMA RR et al:A double-blind randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly pa-tients.Br.J. Clin. Pharmacol.(1991) 45:255–258.
   Google Scholar
• DUNNER DL: Anoverviewofparoxetineintheelderly.Gerontology(1994) 40\(Suppl. 0:21–27.
   Google Scholar
• HEBENSTREIT GF, FELLERER R, ZOCHLING A et al.:Apharmacokinetic dose titration study in adult and eld-erlydepressedpatients.Acta Psychiat. Scand.(1989) (Suppl. 350)81–84.
   Google Scholar
• BAYER AJ, ROBERTS NA, ALLEN EA et al.:Thepharma-cokineticsofparoxetineintheelderly.Acta Psychiat. Scand.(1989) 80\(Suppl. 350):85–86.
   Google Scholar
• GHOSE K: Thepharmacokineticsofparoxetineineld-/b>erlydepressedpatients.Acta Psychiat. Scand.(1989) 80\(Suppl. 350):87–88.
   Google Scholar
• LUNDMARK J, THOMSEN S, FJORD-LARSEN T et al.:Par-oxetine: pharmacokinetic and antidepressant effect in theelderly.Acta Psychiat. Scand.(1989) 80\(Suppl. 350)76–80.
   Google Scholar
• FURLANUT M, BENETELLO P: Thepharmacokineticsoftricyclicantidepressantdrugsintheelderly.Pharma-col. Res.(1991) 22:15–21.
   Web of Science ®Google Scholar
• BURKARD WP, DA PRADA M, KELLER HH et al.:Preclini-calpharmacologyofmoclobemide.Br. J. Psychiat.(1989) 155 (Suppl. 6):84–88.
   Google Scholar